Hodgkin's Disease — From Pathology Specimen to Cure
- 8 November 2007
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (19), 1968-1971
- https://doi.org/10.1056/nejme078173
Abstract
The history of Hodgkin's disease is one of the most exciting stories in medicine. The disorder accounts for about 1% of all cancers and is curable in 85 to 95% of cases, depending on its stage — whether it is localized or disseminated. Indeed, the article by Fermé et al.1 in this issue of the Journal reports on 10-year survival estimates of 97% for patients with early-stage disease.In 1832, in an article entitled “On Some Morbid Appearances of the Absorbent Glands and Spleen,”2 Thomas Hodgkin discussed six patients with symptoms that differed from those associated with inflammation, tuberculosis, and . . .This publication has 10 references indexed in Scilit:
- Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's DiseaseNew England Journal of Medicine, 2007
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Recent Interim Analysis of the HD11 Trial of the GHSG: Intensification of Chemotherapy and Reduction of Radiation Dose in Early Unfavorable Stage Hodgkin’s Lymphoma.Blood, 2005
- Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2005
- From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potentialBlood, 2005
- HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG)Journal of Clinical Oncology, 2005
- Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975
- Combination Chemotherapy in the Treatment of Advanced Hodgkin's DiseaseAnnals of Internal Medicine, 1970
- NITROGEN MUSTARD THERAPYJournal of the American Medical Association, 1946